August 2026
1. JAISWAL V, Mashkoor Y, Waqas M, Khan MS, et al
   All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors.
   Am J Med. 2026;139:1032-1042.
   

   >> Share

   
   June 2026
2. PAN SY, Weng CH, Sheen YJ, Tsai SF, et al
   GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.
   Am J Med. 2026 Jun 30:S0002-9343(26)00487-0. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   May 2026
3. WU J, Zhao R, Ma Y, Chen Y, et al
   Examining Sleep Quality and Mortality Risks in COPD, Asthma, and Asthma-COPD Overlap Patients.
   Am J Med. 2026 May 11:S0002-9343(26)00378-5. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   April 2026
4. GOLDHABER SZ, Rashedi S, Pfeferman M, Leyva H, et al
   Electronic Alert-Based Computerized Decision Support for Detection of Chronic Kidney Disease in Type 2 Diabetes Mellitus: The CKD-DETECT Randomized Trial.
   Am J Med. 2026 Apr 22:S0002-9343(26)00297-4. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
5. RAO AK, Ibrahim A, Rockey DC
   The effect of SGLT-2 inhibitors on portal hypertensive complications and mortality in patients with cirrhosis.
   Am J Med. 2026 Apr 17:S0002-9343(26)00294-9. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
6. JOSHI D
   Ophthalmic safety considerations when initiating GLP-1 receptor agonists in patients with diabetic retinopathy.
   Am J Med. 2026;139:e122.
   

   >> Share

   
   March 2026
7. TAY WL, Chay J, Hawkins R, Li BV, et al
   Discordantly low HbA1c revealing undiagnosed G6PD deficiency in a patient with type 2 diabetes mellitus.
   Am J Med. 2026 Mar 19:S0002-9343(26)00214-7. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
8. HANIF M, Nagarajan JS, Murphy R, Sah SP, et al
   Glucagon-Like Peptide-1 Receptor Agonist and Lupus Nephritis in Systemic Lupus Erythematosus with Type 2 Diabetes.
   Am J Med. 2026 Mar 9:S0002-9343(26)00146-4. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
9. DEEDWANIA P, Banga A
   Sodium-Glucose Cotransporter 1&2 Inhibitors in Heart Failure and Diabetes Mellitus: From Foundational Therapy to Emerging Frontiers.
   Am J Med. 2026 Mar 8:S0002-9343(26)00177-4. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
10. POWER MC, Madsen M, Bodkergaard K, Zimmerman SC, et al
    Early glycemic control and subsequent risk of incident dementia among new metformin users.
    Am J Med. 2026;139:321-332.
    

    >> Share

    
    December 2025
11. CHUNG J, Park S, Park SJ, Kim HJ, et al
    Fracture Risk by Post-Cessation Weight Change in Men With Newly Diagnosed Type 2 Diabetes.
    Am J Med. 2025 Dec 20:S0002-9343(25)00838-1. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    
12. CHEN JJ, Tsai MH, Ho WY, Fang YW, et al
    Cardio-renal Outcomes in Type 2 Diabetes Patients with Advanced Chronic Kidney Disease on SGLT2 inhibitors or GLP-1 receptor agonists.
    Am J Med. 2025 Dec 17:S0002-9343(25)00839-3. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    
13. HASHIMOTO Y, Fujikawa T
    Severe CA19-9 Elevation in Diabetes: A Pancreatic Cancer Pitfall.
    Am J Med. 2025 Dec 13:S0002-9343(25)00847-2. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    September 2025
14. SANTANA R, Umana CD, Oo ZT, Kolli ST, et al
    Optimizing Guideline-Directed Medical Therapy in Chronic Kidney Disease and Type 2 Diabetes Mellitus Patients in Primary Care.
    Am J Med. 2025 Sep 1:S0002-9343(25)00562-5. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    August 2025
15. YANG Y, Zhang X, Guo J, Zhai R, et al
    Transient Diabetes Insipidus Following Septic Shock due to Non-Intracranial Infection.
    Am J Med. 2025 Aug 30:S0002-9343(25)00571-6. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    
16. KURAMOTO N, Hironaka J, Okada H, Hasegawa Y, et al
    A Meta-Analysis of Available Data of the Effects of Selected Whole and Powdered Fruits on Glycemia in Type 2 Diabetes.
    Am J Med. 2025 Aug 15:S0002-9343(25)00528-5. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    June 2025
17. MOIZ A, Filion KB, Tsoukas MA, Yu OH, et al
    Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation.
    Am J Med. 2025;138:934-940.
    

    >> Share

    
    May 2025
18. KUSUM DATTA A MBBS MRCP MD DM , Majhi A MBBS MD
    Isolated diabetic third cranial palsy with MRI enhancement.
    Am J Med. 2025 May 30:S0002-9343(25)00352-3. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    
19. LEE CW, Myung SK
    Consumption of fruit juice and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies: Fruit Juice and Risk of Type 2 Diabetes.
    Am J Med. 2025 May 18:S0002-9343(25)00303-1. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    
20. LI J, Li J, Fu Y, Zhang K, et al
    Socioeconomic deprivation, unhealthy lifestyle, and premature mortality in patients with type 2 diabetes: A population-based longitudinal study.
    Am J Med. 2025 May 5:S0002-9343(25)00282-7. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    March 2025
21. ANDERSON JE, Leahy JJL
    Injecting New Ideas Into Managing Type 2 Diabetes: Evolving Roles of GLP-1 Receptor Agonists.
    Am J Med. 2025;138:e48.
    

    >> Share

    
    January 2025
22. CHEN VL, Tedesco NR, Hu J, Jasty VSJ, et al
    Rurality and neighborhood socioeconomic status are associated with overall and cause-specific mortality and hepatic decompensation in type 2 diabetes.
    Am J Med. 2025 Jan 20:S0002-9343(25)00036-1. doi: 10.1016/j.amjmed.2025.
    

    >> Share

    
    November 2024
23. SMATI H, Qadeer YK, Rodriguez M, Moras E, et al
    Diabetic Cardiomyopathy: What Clinicians Should Know.
    Am J Med. 2024 Nov 4:S0002-9343(24)00695-8. doi: 10.1016/j.amjmed.2024.
    

    >> Share

    
    
24. JAISWAL V, Mashkoor Y, Raj N, Rajak K, et al
    Association Between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials.
    Am J Med. 2024;137:1136-1141.
    

    >> Share

    
    September 2024
25. LEE BK, Pak K, Pockros PK
    Latent Autoimmune Diabetes in Adults (LADA) Occurring in a Patient with Primary Biliary Cholangitis.
    Am J Med. 2024 Sep 18:S0002-9343(24)00582-5. doi: 10.1016/j.amjmed.2024.
    

    >> Share

    
    August 2024
26. GARCIA-VEGA D, Cinza-Sanjurjo S, Eiras S, Gonzalez-Juanatey JR, et al
    Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry.
    Am J Med. 2024;137:761-769.
    

    >> Share

    
    April 2024
27. SHANI M, Lustman A, Comaneshter D, Schonmann Y, et al
    Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes.
    Am J Med. 2024 Apr 23:S0002-9343(24)00243-2. doi: 10.1016/j.amjmed.2024.
    

    >> Share

    
    March 2024
28. ASHIQUE S, Mishra N, Garg A, Garg S, et al
    A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes.
    Am J Med. 2024 Mar 12:S0002-9343(24)00133-5. doi: 10.1016/j.amjmed.2024.
    

    >> Share

    
    
29. KRITTANAWONG C, Escobar J, Virk HUH, Alam M, et al
    Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease.
    Am J Med. 2024;137:202-209.
    

    >> Share

    
    February 2024
30. ZUNIGA-HERNANDEZ JA, Gamboa-Meza A, Medina-Ramirez HA, Nanez-Terreros H, et al
    Pulmonary Coccidioidomycosis Presenting as Recurrent Diabetic Ketoacidosis.
    Am J Med. 2024 Feb 22:S0002-9343(24)00095-0. doi: 10.1016/j.amjmed.2024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share